1WHO expert consultation on rabies,1st report.Technical reportseries no.931[R].Geneva:World Health Organization.2005.
2Association for the Prevention and Control of Rabies in India.Assessing the burden of rabies in India:a national multicentricsurvey.[R].Bhubaneswar,India:Association for the Preven-tion and Control of Rabies.2003.
3卫生部.中国狂犬病防治现状[R].2009.
4Fenje P.Propagation of rabies virus in cultures of hamster cells[J].Can JMicrobiol,1960,6:479-84.
5Abelseth MK.An attenuated rabies vaccine for domestic animalsproduced in tissue culture[J].Can Vet J,1964,5:279-86.
6Steck F,Haeflinger U,Stocker C.Oral immunization of foxes a-gainst rabies[J].Experientia,1978,34:1662.
7Schneider LG.Tollwut-Lebendimpfstoff(sicher in Englisch)[R].European Patent Office,1993.
8Tuffereau C.Arginine or lysine in position 333of ERA and CVSglycoprotein is necessary for rabies virulence in adult mice[J].Virology,1989Sep,172(1):206-12.
9Artois M,Cliquet F,Barrat J.Effectiveness of SAG1oral vac-cine for the long-term protection of red foxes(Vulpes vulpes)a-gainst rabies[J].Vet Rec 1997,140:57-9.
10Lafay F,Benejean J,Tuffereau C.Vaccination against rabies:construction and characterization of SAG2,a double avirulentderivative of SAD Bern[J].Vaccine,1994,12:317-20.
9WHO expert consultation on rabies, 1st report. Technical report series no. 931 [R]. Geneva : World Health Oraganization, 2005.
10Tordo N,Poch O, Ermine A, et al. Walking along the rabies ge nome:Is the large G-Lintergenic region a remnant gene[J]. Porc Natl Acad Sci USA,1986,83:3914-8.
